Drugs / TeaRx
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03088358 | Aug 2013 → Sep 2015 | — | TeaRx LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TeaRx | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03088358 ↗ |
| Action | Inhibit | “TeaRx Xa Factor Direct Inhibitor” NCT03088358 ↗ |
| Route | Oral | “TeaRx: 50 mg per day PO” NCT03088358 ↗ |